NASDAQ · Biotechnology
MeiraGTx Holdings plc (MGTX) Stock
$10.69
+1.81%
NASDAQ: MGTX
Healthcare
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Latest News
MeiraGTx (MGTX) Moves 5.5% Higher: Will This Strength Last?
Zacks · Jul 8, 2026
RBC Capital Adjusts MeiraGTx Price Target to $26 From $25, Maintains Outperform Speculative Risk Rating
MT Newswires · Jul 8, 2026
Top Midday Gainers
MT Newswires · Jul 7, 2026
MeiraGTx Announces $400 million Strategic Investment by Oberland Capital to Support Development and Commercialization of AAV2-hAQP1 and Botaretigene Sparoparvovec (bota-vec)
GlobeNewswire · Jul 7, 2026
Can MeiraGTx Holdings PLC (MGTX) Stock Double? Cash Runway Offers a Hint
Insider Monkey · May 20, 2026
Cash Flow (USD)
Valuation & Return Ratios
Ownership
Insiders Held17.12%
Institutions Held61.14%
Institutions Float Held73.77%
Peer Comparison
About MeiraGTx Holdings plc
MeiraGTx Holdings plc is led by CEO Alexandria Forbes, employs 375 people, headquartered in US, publicly traded since 2018.
MeiraGTx Holdings plc (MGTX) stock trades at $10.69 with a market capitalization of $990.00M. The stock is valued at a price-to-earnings (P/E) ratio of 17.43, price-to-book of 5.62, price-to-sales of 3.09. Over the past 52 weeks the stock has ranged between $6.62 and $15.35, and currently trades 30.4% below its 52-week high.
On profitability, MeiraGTx Holdings plc generates a return on equity (ROE) of 284.38% — well above the market average, a sign of a high-quality business, return on capital employed of 54.39%, an operating margin of -130.86%, a net profit margin of 19.87%.